Pelorus Equity Group

Pelorus Equity Group is a prominent provider of value-add bridge commercial real estate loans within the cannabis sector. The company specializes in offering flexible acquisition and bridge lending programs tailored to the unique needs of cannabis businesses and real estate owners. Their Pelorus Fund, a private mortgage real estate investment trust (mREIT), has been involved in over 5,000 transactions, deploying more than $500 million across nearly 4,200,000 square feet in eight U.S. states. This extensive experience enables Pelorus to rapidly assess opportunities, structure effective solutions, and execute timely closings.

The firm's investment strategy focuses on providing non-dilutive real estate debt financing to cannabis operators, facilitating facility improvements, build-outs, and expansions. Notable transactions include a $19 million construction-financing loan to Item 9 Labs Corp. for the expansion of cultivation and lab sites in Arizona and Nevada, and a $15.8 million debt financing arrangement with TransCanna Holdings Inc. to refinance and develop a California facility. These investments underscore Pelorus's commitment to supporting the growth and development of leading cannabis businesses through strategic real estate financing.

Pelorus Equity Group's track record reflects significant growth and industry leadership. In 2021, the company achieved a 434% year-over-year growth, ending the year with $243 million in assets under management and $193 million in equity. This performance highlights Pelorus's ability to navigate the evolving cannabis market and deliver value to its investors and partners. The firm's strategic focus on real estate lending within the cannabis industry positions it as a key player in facilitating the sector's expansion and maturation.